טוען...
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Current approaches to prevent and treat graft-versus-host disease (GVHD) after stem cell transplantation rely principally on pharmacological immune suppression. Such approaches are limited by drug toxicity, nonspecific immune suppression, and a requirement for long-term therapy. Our increased unders...
שמור ב:
| הוצא לאור ב: | Blood |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032895/ https://ncbi.nlm.nih.gov/pubmed/29728401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-785865 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|